SNNC (Sibannac) EBITDA Margin %: 0.00% (As of Feb. 2017)


What is Sibannac EBITDA Margin %?

Sibannac SNNC -29.41% EBITDA Margin % is 0.00% as of Feb. 2017.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Sibannac's EBITDA for the three months ended in Feb. 2017 was $-0.01 Mil. Sibannac's Revenue for the three months ended in Feb. 2017 was $0.00 Mil. Therefore, Sibannac's EBITDA margin for the quarter that ended in Feb. 2017 was 0.00%.

Sibannac  (OTCPK:SNNC) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Sibannac EBITDA Margin % Related Terms

Sibannac EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Sibannac's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sibannac EBITDA Margin % Chart

Sibannac Annual Data
Trend Aug11 Aug12 Aug13 Aug14 Aug15 Aug16
EBITDA Margin %
Get a 7-Day Free Trial -72.22 -63.29 0.00 0.00 0.00

Sibannac Quarterly Data
May12 Aug12 Nov12 Feb13 May13 Aug13 Nov13 Feb14 May14 Aug14 Nov14 Feb15 May15 Aug15 Nov15 Feb16 May16 Aug16 Nov16 Feb17
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -134.23 -42.70 -2.38 -180.49 0.00

SNNC vs LIVC, OTTV, FPTA: EBITDA Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Sibannac's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sibannac EBITDA Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sibannac's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Sibannac's EBITDA Margin % falls into.


Sibannac EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Sibannac's EBITDA Margin % for the fiscal year that ended in Aug. 2016 is calculated as

EBITDA Margin %=EBITDA (A: Aug. 2016 )/Revenue (A: Aug. 2016 )
=-0.133/0
= %

Sibannac's EBITDA Margin % for the quarter that ended in Feb. 2017 is calculated as

EBITDA Margin %=EBITDA (Q: Feb. 2017 )/Revenue (Q: Feb. 2017 )
=-0.011/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 0.00% mean?
Sibannac (SNNC) has a EBITDA Margin % of 0.00% as of Feb. 2017. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Sibannac and its competitors.
Is Sibannac's EBITDA Margin % too high?
Sibannac's current EBITDA Margin % is 0.00%.
How does Sibannac's EBITDA Margin % compare to LIVC and OTTV?
Sibannac's EBITDA Margin % of 0.00% can be compared against companies in the Drug Manufacturers industry. The industry median EBITDA Margin % is 12.49. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Drug Manufacturers company?
The median EBITDA Margin % among Drug Manufacturers companies is 12.49, based on 953 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Sibannac and its competitors. For the Drug Manufacturers industry, the median EBITDA Margin % is 12.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sibannac's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sibannac stock overvalued right now?
Sibannac (SNNC) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Sibannac (SNNC), the current EBITDA Margin % is 0.00% as of Feb. 2017. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sibannac Business Description

Address 8657 N Caballo Circle, Paradise Valley, AZ, USA, 85253
Sibannac Inc is a cannabis research and development company with a portfolio of hemp beauty and body products, hemp animal care products, hemp clothing and accessories, and hemp paper and plastic products. Its products include oils, creams, lotions, treats, foods, shirts, pants, and dresses, and it also develops new hemp products. The group manufactures its products in Geneva, New York, and Charlotte, North Carolina. Its subsidiary business units include NOHO, Cherryology, and RaD8 Life, and associated brands include NOHO, Higher Times, Starwalker Cafe, The Meru Sky, consumer brands such as Converse, Titleist, FootJoy, Coca-Cola, Pepperidge Farm, and practitioner and nutraceutical brands including ChiroTouch, Emerson Ecologics, Reserveage, Gaia Herbs, Organic India, and NeoCell.